The KGI Corporate Relations Board provides industry insight, marketplace feedback, and support for KGI’s corporate outreach. The council includes leaders from biotech, pharmaceutical, medical device diagnostic, service, and tools companies.
Vice President, Operations, Ivantis
VP Strategy and Programming, Edwards Lifesciences
Chief Medical Officer, Natera
Manager, Assay R&D, Ortho Clinical Diagnostics
President and CEO, OBMedical Company
VP and Chief Technology Officer, Analytik Jena/(UVP)
Chairman and CEO, Xontogeny
Corporate Strategy and Strategic Analysis, Gossamar Bio
Executive Chairman, Cardea
Biotechnology Executive, Winesprings Consulting
VP Strategy and Business Development, Hologics
Senior Director of Regulatory Affairs, Intercept Pharmaceuticals
Executive Consultant, Progenity, Inc.
Business Development, Jazz Pharmaceuticals
VP of Quality & Regulatory, RTG, Medrontic Neurovascular
Emerging Technology Strategist, Alfred E. Mann Institute - USC
COO, ACell Inc.
CRB Chair; Vice President, EyeGate Pharmaceuticals
Founder & Chief Executive Officer, Sequella, Inc.
Director of Enabling Technologies, Johnson & Johnson DePuy Synthes
Chief Executive Officer, Voxx Analytics
Senior Vice President, Development Operations, Ascendis Pharmaceuticals
Vice President/Head of R&D, Optical Surgery, Johnson & Johnson Vision
Vice President Device Technologies - Retired, Amgen
VP, Business Development, Sage Therapeutics
VP, Biologics Development and Manufacturing, Gilead Sciences
Group VP, Global Supply Chain and Planning, BioMarin Pharmaceuticals
CEO, TRACON Pharmaceuticals, Inc